527 related articles for article (PubMed ID: 20021214)
1. Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation.
Kennedy KM; Dewhirst MW
Future Oncol; 2010 Jan; 6(1):127-48. PubMed ID: 20021214
[TBL] [Abstract][Full Text] [Related]
2. The altered glucose metabolism in tumor and a tumor acidic microenvironment associated with extracellular matrix metalloproteinase inducer and monocarboxylate transporters.
Li X; Yu X; Dai D; Song X; Xu W
Oncotarget; 2016 Apr; 7(17):23141-55. PubMed ID: 27009812
[TBL] [Abstract][Full Text] [Related]
3. A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis.
Su J; Chen X; Kanekura T
Cancer Lett; 2009 Jan; 273(1):140-7. PubMed ID: 18778892
[TBL] [Abstract][Full Text] [Related]
4. CD147 required for corneal endothelial lactate transport.
Li S; Nguyen TT; Bonanno JA
Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4673-81. PubMed ID: 24970254
[TBL] [Abstract][Full Text] [Related]
5. Monocarboxylate transporters 1 and 4 are associated with CD147 in cervical carcinoma.
Pinheiro C; Longatto-Filho A; Pereira SM; Etlinger D; Moreira MA; Jubé LF; Queiroz GS; Schmitt F; Baltazar F
Dis Markers; 2009; 26(3):97-103. PubMed ID: 19597291
[TBL] [Abstract][Full Text] [Related]
6. Expression of monocarboxylate transporters 1, 2, and 4 in human tumours and their association with CD147 and CD44.
Pinheiro C; Reis RM; Ricardo S; Longatto-Filho A; Schmitt F; Baltazar F
J Biomed Biotechnol; 2010; 2010():427694. PubMed ID: 20454640
[TBL] [Abstract][Full Text] [Related]
7. Membrane-anchored carbonic anhydrase IV interacts with monocarboxylate transporters via their chaperones CD147 and GP70.
Forero-Quintero LS; Ames S; Schneider HP; Thyssen A; Boone CD; Andring JT; McKenna R; Casey JR; Deitmer JW; Becker HM
J Biol Chem; 2019 Jan; 294(2):593-607. PubMed ID: 30446621
[TBL] [Abstract][Full Text] [Related]
8. PGC-1alpha increases skeletal muscle lactate uptake by increasing the expression of MCT1 but not MCT2 or MCT4.
Benton CR; Yoshida Y; Lally J; Han XX; Hatta H; Bonen A
Physiol Genomics; 2008 Sep; 35(1):45-54. PubMed ID: 18523157
[TBL] [Abstract][Full Text] [Related]
9. CD147/Basigin Is Involved in the Development of Malignant Tumors and T-Cell-Mediated Immunological Disorders via Regulation of Glycolysis.
Kanekura T
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139173
[TBL] [Abstract][Full Text] [Related]
10. Knock out of the BASIGIN/CD147 chaperone of lactate/H+ symporters disproves its pro-tumour action via extracellular matrix metalloproteases (MMPs) induction.
Marchiq I; Albrengues J; Granja S; Gaggioli C; Pouysségur J; Simon MP
Oncotarget; 2015 Sep; 6(28):24636-48. PubMed ID: 26284589
[TBL] [Abstract][Full Text] [Related]
11. MCT1, MCT4 and CD147 expression and 3-bromopyruvate toxicity in colorectal cancer cells are modulated by the extracellular conditions.
Pereira-Vieira J; Azevedo-Silva J; Preto A; Casal M; Queirós O
Biol Chem; 2019 May; 400(6):787-799. PubMed ID: 30699066
[TBL] [Abstract][Full Text] [Related]
12. Exercise-induced changes in tumour LDH-B and MCT1 expression are modulated by oestrogen-related receptor alpha in breast cancer-bearing BALB/c mice.
Aveseh M; Nikooie R; Aminaie M
J Physiol; 2015 Jun; 593(12):2635-48. PubMed ID: 25907793
[TBL] [Abstract][Full Text] [Related]
13. CD147: a small molecule transporter ancillary protein at the crossroad of multiple hallmarks of cancer and metabolic reprogramming.
Kendrick AA; Schafer J; Dzieciatkowska M; Nemkov T; D'Alessandro A; Neelakantan D; Ford HL; Pearson CG; Weekes CD; Hansen KC; Eisenmesser EZ
Oncotarget; 2017 Jan; 8(4):6742-6762. PubMed ID: 28039486
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms regulating tissue-specific polarity of monocarboxylate transporters and their chaperone CD147 in kidney and retinal epithelia.
Deora AA; Philp N; Hu J; Bok D; Rodriguez-Boulan E
Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16245-50. PubMed ID: 16260747
[TBL] [Abstract][Full Text] [Related]
15. Genetic disruption of lactate/H+ symporters (MCTs) and their subunit CD147/BASIGIN sensitizes glycolytic tumor cells to phenformin.
Marchiq I; Le Floch R; Roux D; Simon MP; Pouyssegur J
Cancer Res; 2015 Jan; 75(1):171-80. PubMed ID: 25403912
[TBL] [Abstract][Full Text] [Related]
16. CD147 augmented monocarboxylate transporter-1/4 expression through modulation of the Akt-FoxO3-NF-κB pathway promotes cholangiocarcinoma migration and invasion.
Dana P; Saisomboon S; Kariya R; Okada S; Obchoei S; Sawanyawisuth K; Wongkham C; Pairojkul C; Wongkham S; Vaeteewoottacharn K
Cell Oncol (Dordr); 2020 Apr; 43(2):211-222. PubMed ID: 31729681
[TBL] [Abstract][Full Text] [Related]
17. Monocarboxylate transporters in cancer.
Payen VL; Mina E; Van Hée VF; Porporato PE; Sonveaux P
Mol Metab; 2020 Mar; 33():48-66. PubMed ID: 31395464
[TBL] [Abstract][Full Text] [Related]
18. Cysteine 159 delineates a hinge region of the alternating access monocarboxylate transporter 1 and is targeted by cysteine-modifying inhibitors.
Köpnick AL; Geistlinger K; Beitz E
FEBS J; 2021 Oct; 288(20):6052-6062. PubMed ID: 33999492
[TBL] [Abstract][Full Text] [Related]
19. CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models.
Schneiderhan W; Scheler M; Holzmann KH; Marx M; Gschwend JE; Bucholz M; Gress TM; Seufferlein T; Adler G; Oswald F
Gut; 2009 Oct; 58(10):1391-8. PubMed ID: 19505879
[TBL] [Abstract][Full Text] [Related]
20. Basigin interacts with both MCT1 and MCT2 in murine spermatozoa.
Mannowetz N; Wandernoth P; Wennemuth G
J Cell Physiol; 2012 May; 227(5):2154-62. PubMed ID: 21792931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
